233
Views
43
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Late cardiac toxicity secondary to treatment in Hodgkin's disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy

, , , , &
Pages 1023-1028 | Received 17 Jan 2005, Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Mehul Dalal, Jatin Gupta, Kim Price, Athanasios Zomas, Harry Miao & Ajibade Ashaye. (2020) Efficacy and safety of front-line treatments for advanced Hodgkin lymphoma: a systematic literature review. Expert Review of Hematology 13:8, pages 907-922.
Read now
Mohamed Gomaa Kamel, Amr Ehab El-Qushayri, Tran Quang Thach & Nguyen Tien Huy. (2018) Cardiovascular mortality trends in non-Hodgkin’s lymphoma: a population-based cohort study. Expert Review of Anticancer Therapy 18:1, pages 91-100.
Read now
Ming Hui Chen, Lauren H. Blackington, Jing Zhou, Tammy F. Chu, Kimberlee Gauvreau, Karen J. Marcus, David C. Fisher, Lisa R. Diller & Andrea K. Ng. (2014) Blood pressure is associated with occult cardiovascular disease in prospectively studied Hodgkin lymphoma survivors after chest radiation. Leukemia & Lymphoma 55:11, pages 2477-2483.
Read now

Articles from other publishers (40)

Melanie Powis, Saidah Hack, Rouhi Fazelzad, David Hodgson & Vishal Kukreti. (2023) Survivorship care for patients curatively treated for Hodgkin’s and non-Hodgkin’s lymphoma: a scoping review. Journal of Cancer Survivorship.
Crossref
Jayakumar Sreenivasan, Urvashi Hooda, Pragya Ranjan & Diwakar Jain. (2021) Nuclear Imaging for the Assessment of Cardiotoxicity from Chemotherapeutic Agents in Oncologic Disease. Current Cardiology Reports 23:6.
Crossref
Serhan KÜPELİ. (2019) Cardiac and pulmonary late side effects after Hodgkin lymphomaHodgkin lenfoma sonrası kalpte ve akciğerde görülen geç yan etkiler. Cukurova Medical Journal 44:4, pages 1468-1472.
Crossref
S. Lautenschlaeger, G. Iancu, V. Flatten, K. Baumann, M. Thiemer, C. Dumke, K. Zink, H. Hauswald, D. Vordermark, C. Mauz-Körholz, R. Engenhart-Cabillic & F. Eberle. (2019) Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin’s disease. Radiation Oncology 14:1.
Crossref
Devon J. Boyne, Alexis T. Mickle, Darren R. Brenner, Christine M. Friedenreich, Winson Y. Cheung, Karen L. Tang, Todd A. Wilson, Diane L. Lorenzetti, Matthew T. James, Paul E. Ronksley & Doreen M. Rabi. (2018) Long‐term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta‐analysis. Cancer Medicine 7:9, pages 4801-4813.
Crossref
Saro H. ArmenianChristina LacchettiAna BaracJoseph CarverLouis S. ConstineNeelima DenduluriSusan DentPamela S. DouglasJean-Bernard DurandMichael EwerCarol FabianMelissa HudsonMariell JessupLee W. JonesBonnie KyErica L. MayerJavid MoslehiKevin OeffingerKatharine RayKathryn RuddyDaniel Lenihan. (2017) Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology 35:8, pages 893-911.
Crossref
Andrea K. Ng, Lawrence M. Weiss & Ann S. LaCasce. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology 1506 1523.e5 .
Klaus MurbraechKnut B. SmelandHarald HolteJon Håvard LogeMay Brit LundTorgeir WethalEspen HolteAssami RösnerHåvard DalenStein KvaløyRagnhild S. FalkSvend AakhusCecilie E. Kiserud. (2015) Heart Failure and Asymptomatic Left Ventricular Systolic Dysfunction in Lymphoma Survivors Treated With Autologous Stem-Cell Transplantation: A National Cross-Sectional Study. Journal of Clinical Oncology 33:24, pages 2683-2691.
Crossref
K. Behringer, T.V. Halbsguth & P. Borchmann. (2014) Spätschäden und Survivorship nach Behandlung des Hodgkin-LymphomsLate sequelae and survivorship following treatment of Hodgkin’s lymphoma. Der Onkologe 20:5, pages 470-476.
Crossref
Zhih-Cherng Chen, Li-Jen Chen & Juei-Tang Cheng. (2013) Doxorubicin-Induced Cardiac Toxicity Is Mediated by Lowering of Peroxisome Proliferator-Activated Receptor δ Expression in Rats . PPAR Research 2013, pages 1-8.
Crossref
Stephanie A. Terezakis & Yvette L. Kasamon. (2012) Tailored strategies for radiation therapy in classical Hodgkin's lymphoma. Critical Reviews in Oncology/Hematology 84:1, pages 71-84.
Crossref
Pinki K. Prasad, Lisa B. Signorello, Debra L. Friedman, John D. BoiceJr.Jr. & Eero Pukkala. (2011) Long‐term non‐cancer mortality in pediatric and young adult cancer survivors in Finland. Pediatric Blood & Cancer 58:3, pages 421-427.
Crossref
Anne W Beaven & David Rizzieri. (2012) Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkin’s lymphoma. Clinical Investigation 2:1, pages 49-58.
Crossref
Andrea K. Ng, Lawrence Weiss & Ann S. LaCasce. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology 1527 1543 .
Vishnu Chintalgattu & Aarif Y. Khakoo. 2012. Translational Cardiology. Translational Cardiology 291 316 .
Saro H. ArmenianCan-Lan SunTabitha ShannonGeorge MillsLiton FranciscoKalyanasundaram Venkataraman, F. Lennie WongStephen J. Forman & Smita Bhatia. (2011) Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation. Blood 118:23, pages 6023-6029.
Crossref
Andrea K. Ng. (2011) Review of the cardiac long-term effects of therapy for Hodgkin lymphoma. British Journal of Haematology 154:1, pages 23-31.
Crossref
Joachim Yahalom & Carol S. Portlock. (2011) Long-Term Cardiac and Pulmonary Complications of Cancer Therapy. Heart Failure Clinics 7:3, pages 403-411.
Crossref
Nabanita Patra, Umasankar De, Jin-Ah Kang, Ji Mim Kim, Mee Young Ahn, Jaewon Lee, Jee H. Jung, Hae Young Chung, Hyung Ryong Moon & Hyung Sik Kim. (2011) A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells. European Journal of Pharmacology 658:2-3, pages 98-107.
Crossref
Shira L. GalperJames B. YuPeter M. MauchJon F. StrasserBarbara SilverAnn LaCasceKaren J. MarcusMary Ann Stevenson, Ming Hui Chen & Andrea K. Ng. (2011) Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood 117:2, pages 412-418.
Crossref
Aarif Y. Khakoo & Callie S. Kwartler. 2011. Pulmonary Involvement in Patients with Hematological Malignancies. Pulmonary Involvement in Patients with Hematological Malignancies 87 115 .
Lena Specht & Andrea K. Ng. 2011. Radiotherapy for Hodgkin Lymphoma. Radiotherapy for Hodgkin Lymphoma 7 20 .
Andrea K. Ng & Lois B. Travis. 2011. Radiotherapy for Hodgkin Lymphoma. Radiotherapy for Hodgkin Lymphoma 183 196 .
Jean-François Morère, Françoise Mornex & Denis SoulièresP. Colonna & J.-M. Andrieu. 2011. Thérapeutique du cancer. Thérapeutique du cancer 793 815 .
Elvira C van Dalen, Erna MC Michiels, Huib N Caron & Leontien CM Kremer. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Serhan KüpeliTuncay HazırolanAli VaranDeniz AkataDursun AlehanMutlu HayranAytekin BesimMünevver Büyükpamukçu. (2010) Evaluation of Coronary Artery Disease by Computed Tomography Angiography in Patients Treated for Childhood Hodgkin's Lymphoma. Journal of Clinical Oncology 28:6, pages 1025-1030.
Crossref
Aileen B. ChenRinaa S. PungliaKaren M. KuntzPeter M. MauchAndrea K. Ng. (2009) Cost Effectiveness and Screening Interval of Lipid Screening in Hodgkin's Lymphoma Survivors. Journal of Clinical Oncology 27:32, pages 5383-5389.
Crossref
Corinne Brillant, Kathrin Bauer, Christine Herbst, Ina Monsef, Nicole Skoetz & Andreas Engert. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Andrea K. Ng & Peter M. Mauch. (2009) Late Effects of Hodgkin’s Disease and Its Treatment. The Cancer Journal 15:2, pages 164-168.
Crossref
Andrea K. Ng. (2008) Late complications after treatment for Hodgkin lymphoma. Current Hematologic Malignancy Reports 3:3, pages 119-125.
Crossref
Joachim Yahalom & Carol S. Portlock. (2008) Long-Term Cardiac and Pulmonary Complications of Cancer Therapy. Hematology/Oncology Clinics of North America 22:2, pages 305-318.
Crossref
PAULA KLEMM. (2008) Late Effects of Treatment for Long-term Cancer Survivors. CIN: Computers, Informatics, Nursing 26:1, pages 49-58.
Crossref
Angela Dispenzieri. (2007) Complications of Myeloma Therapy. Hematology/Oncology Clinics of North America 21:6, pages 1247-1273.
Crossref
Joachim Yahalom. (2007) Introduction. Seminars in Radiation Oncology 17:3, pages 157.
Crossref
Theodore Girinsky & Mithra Ghalibafian. (2007) Radiotherapy of Hodgkin Lymphoma: Indications, New Fields, and Techniques. Seminars in Radiation Oncology 17:3, pages 206-222.
Crossref
Alan Pourpak, Terry H. Landowski & Robert T. Dorr. (2007) Ethonafide-Induced Cytotoxicity Is Mediated by Topoisomerase II Inhibition in Prostate Cancer Cells. Journal of Pharmacology and Experimental Therapeutics 321:3, pages 1109-1117.
Crossref
Berthe M. P. AlemanAlexandra W. van den Belt-DuseboutMarie L. De BruinMars B. van 't VeerMargreet H. A. BaaijensJan Paul de Boer, Augustinus A. M. HartWillem J. KlokmanMarianne A. KuenenGabey M. OuwensHarry BartelinkFlora E. van Leeuwen. (2006) Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109:5, pages 1878-1886.
Crossref
Anthony J. Swerdlow, Craig D. Higgins, Paul Smith, David Cunningham, Barry W. Hancock, Alan Horwich, Peter J. Hoskin, Andrew Lister, John A. Radford, Ama Z. S. Rohatiner & David C. Linch. (2007) Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study. JNCI: Journal of the National Cancer Institute 99:3, pages 206-214.
Crossref
. (2006) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 15:1, pages i-xii.
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 23:3-4, pages 136-143.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.